- Home
- IMMP vs AGD Comparison
IMMP vs AGD Comparison
Compare IMMP & AGD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMMP
- AGD
- Stock Information
- Founded
- IMMP 1987
- AGD 2006
- Country
- IMMP Australia
- AGD United Kingdom
- Employees
- IMMP N/A
- AGD N/A
- Industry
- IMMP Biotechnology: Pharmaceutical Preparations
- AGD Trusts Except Educational Religious and Charitable
- Sector
- IMMP Health Care
- AGD Finance
- Exchange
- IMMP Nasdaq
- AGD Nasdaq
- Market Cap
- IMMP 211.1M
- AGD 235.0M
- IPO Year
- IMMP N/A
- AGD N/A
- Fundamental
- Price
- IMMP $1.89
- AGD $10.16
- Analyst Decision
- IMMP Buy
- AGD
- Analyst Count
- IMMP 2
- AGD 0
- Target Price
- IMMP $8.50
- AGD N/A
- AVG Volume (30 Days)
- IMMP 659.8K
- AGD 61.2K
- Earning Date
- IMMP 05-23-2025
- AGD 01-01-0001
- Dividend Yield
- IMMP N/A
- AGD 8.13%
- EPS Growth
- IMMP N/A
- AGD N/A
- EPS
- IMMP N/A
- AGD N/A
- Revenue
- IMMP $3,019,249.00
- AGD N/A
- Revenue This Year
- IMMP $50.37
- AGD N/A
- Revenue Next Year
- IMMP N/A
- AGD N/A
- P/E Ratio
- IMMP N/A
- AGD N/A
- Revenue Growth
- IMMP 24.11
- AGD N/A
- 52 Week Low
- IMMP $1.32
- AGD $8.20
- 52 Week High
- IMMP $3.34
- AGD $9.78
- Technical
- Relative Strength Index (RSI)
- IMMP 54.39
- AGD 59.69
- Support Level
- IMMP $1.78
- AGD $10.02
- Resistance Level
- IMMP $2.71
- AGD $10.40
- Average True Range (ATR)
- IMMP 0.17
- AGD 0.16
- MACD
- IMMP 0.02
- AGD 0.04
- Stochastic Oscillator
- IMMP 25.45
- AGD 68.00
About IMMP Immutep Limited
Immutep Ltd is a globally active biotechnology company developing immunotherapy products for cancer and autoimmune diseases. Its main product is IMP321, which involves clinical development for the treatment of cancer indications. The company is also focused on the development of other products, which include IMP701, which is a blocking anti-LAG-3 antibody for cancer and is in Phase I of its clinical trials, and CVac, which is a personalized immunocellular therapeutic investigated for the treatment of epithelial cancer. Geographically all the business activity of the firm is functioned through the region of Australia.
About AGD abrdn Global Dynamic Dividend Fund of Beneficial Interest
Aberdeen Global Dynamic Dividend Fund is a diversified, closed-end management investment company. The fund's primary investment objective is to seek high current dividend income, more than 50% of which qualifies for the reduced federal income tax rate, as created by the Jobs and Growth Tax Relief Reconciliation Act of 2003. The fund also focuses on the long-term growth of capital as a secondary investment objective. The fund's portfolio holdings are in information technology, financials, health care, and consumer discretionary sectors among others.